Table III.
Odds ratios (OR) for OOH users within each of the five disease groups for getting in contact with the healthcare system or dying during the 30-day follow-up (patients without chronic disease served as reference group).1,2
| Odds ratio (95% CI) | |||||||||||||||||||||||||||||||
| OOH | Daytime GP | Hospital admission | Death | ||||||||||||||||||||||||||||
| Crude | Adjusted3 | Crude | Adjusted3 | Crude | Adjusted3 | Crude | Adjusted3 | ||||||||||||||||||||||||
| Heart disease | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.17 | (0.04;0.69) | 0.32 | (0.08;1.30) | 0.90 | (0.53;1.51) | 0.67 | (0.39;1.18) | 2.27 | (1.25;4.11) | 1.64 | (0.90;3.01) | 14.98 | (5.62;39.95) | 4.71 | (1.80;12.30) | |||||||||||||||
| New health problem | 1.16 | (0.45;2.96) | 2.30 | (0.90;5.93) | 1.03 | (0.73;1.44) | 0.82 | (0.57;1.18) | 2.03 | (1.35;3.04) | 1.41 | (0.92;2.14) | 17.17 | (8.37;35.25) | 3.00 | (1.39;6.51) | |||||||||||||||
| Lung disease: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.46 | (0.25;0.83) | 0.75 | (0.40;1.38) | 0.98 | (0.75;1.29) | 0.76 | (0.57;1.02) | 1.46 | (1.07;2.01) | 1.13 | (0.82;1.59) | 14.93 | (7.76;28.72) | 5.42 | (2.82;10.40) | |||||||||||||||
| New health problem | 0.94 | (0.56;1.59) | 1.27 | (0.90;1.80) | 1.08 | (0.9;1.30 | 0.93 | (0.78;1.14) | 1.36 | (1.09;1.70) | 1.18 | (0.94;1.48) | 5.57 | (3.06;5.80) | 2.03 | (1.43;2.88) | |||||||||||||||
| Diabetes: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.63 | (0.19;2.09) | 1.27 | (0.37;4.36) | 0.95 | (0.69;1.31) | 0.77 | (0.55;1.09) | 1.36 | (0.90;2.03) | 1.01 | (0.67;1.52) | 17.49 | (8.76;34.93) | 5.83 | (2.74;12.39) | |||||||||||||||
| New health problem | 0.95 | (0.55;1.65) | 1.63 | (0.90;2.95) | 1.47 | (1.21;1.76) | 1.25 | (1.03;1.52) | 1.66 | (1.34;2.05) | 1.32 | (1.05;1.65) | 6.96 | (4.09;11.85) | 2.82 | (1.53;5.14) | |||||||||||||||
| Psychiatric disease: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.25 | (0.09;0.70) | 0.34 | (0.12;0.96) | 0.34 | (0.19;0.61) | 0.31 | (0.17;0.57) | 1.84 | (1.03;3.29) | 1.64 | (0.91;2.94) | 0.77 | (0. 18;3.28) | 1.62 | (0.33;7.87) | |||||||||||||||
| New health problem | 2.23 | (1.08;4.63) | 2.45 | (1.18;5.08) | 0.76 | (0.53;1.08) | 0.78 | (0.51;1.05) | 1.49 | (0.98;2.26) | 1.46 | (0.95;2.25) | 0.33 | (0.0.8;1.40) | 0.81 | (0.16;4.01) | |||||||||||||||
| Cancer: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.63 | (0.21;1.85) | 1.03 | (0.35;3.08) | 0.86 | (0.61;1.22) | 0.67 | (0.47;0.96) | 1.60 | (1.02;2.49) | 1.24 | (0.99;1.93) | 30.76 | (16.43;57.61) | 12.65 | (6.19;25.87) | |||||||||||||||
| New health problem | 0.58 | (0.31;1.11) | 0.90 | (0.48;1.70) | 1.35 | (1.12;1.62) | 1.06 | (0.87;1.28) | 1.54 | (1.23;1.93) | 1.23 | (0.98;1.56) | 11.67 | (7.10;19.17) | 4.06 | (2.40;6.90) | |||||||||||||||
| 2 + diagnosed: | |||||||||||||||||||||||||||||||
| Reference | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||
| Exacerbation | 0.34 | (0.15;0.79) | 0.67 | (0.29;1.58) | 0.65 | (0.46;0.92) | 0.47 | (0.33;0.69) | 2.39 | (1.59;3.59) | 1.71 | (1.12;2.61) | 25.68 | (12.97;50.86) | 8.97 | (4.55;17.68) | |||||||||||||||
| New health problem | 0.53 | (0.22;1.27) | 0.91 | (0.39;2.12) | 1.26 | (1.00;1.59) | 0.99 | (0.77;1.26) | 1.00 | (0.90;1.10) | 1.00 | (0.92;1.11) | 12.33 | (7.06;21.53) | 3.96 | (2.18;7.19) | |||||||||||||||
Notes: 1Patients without any of the five chronic diseases served as reference group. 2Contact distribution-related weighted estimates (95% confidence interval). 3Adjusted for gender and age.